Citation: Oa. Badary et Amg. El-din, Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis, CANCER DET, 25(4), 2001, pp. 362-368
Authors:
Al-Shabanah, OA
El-Kashef, HA
Badary, OA
Al-Bekairi, AM
Elmazar, MMA
Citation: Oa. Al-shabanah et al., Effect of streptozotocin-induced hyperglycaemia on intravenous pharmacokinetics and acute cardiotoxicity of doxorubicin in rats, PHARMAC RES, 41(1), 2000, pp. 31-37
Authors:
Badary, OA
Sharaby, SM
Kenawy, SA
El-Denshary, EE
Hamada, FMA
Citation: Oa. Badary et al., Evaluation of cisplatin combined with ondansetron in Ehrlich ascites carcinoma in vitro and in vivo, TUMORI, 86(2), 2000, pp. 153-156
Authors:
Badary, OA
Abdel-Naim, AB
Adel-Wahab, MH
Hamada, FMA
Citation: Oa. Badary et al., The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats, TOXICOLOGY, 143(3), 2000, pp. 219-226
Authors:
Badary, OA
Abdel-Naim, AB
Khalifa, AE
Hamada, FMA
Citation: Oa. Badary et al., Differential alteration of cisplatin cytotoxicity and myelotoxicity by thepaclitaxel vehicle cremophor EL, N-S ARCH PH, 361(3), 2000, pp. 339-344
Authors:
Nagi, MN
Alam, K
Badary, OA
Al-Shabanah, OA
Al-Sawaf, HA
Al-Bekairi, AM
Citation: Mn. Nagi et al., Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism, BIOC MOL B, 47(1), 1999, pp. 153-159
Authors:
Badary, OA
Al-Shabanah, OA
Nagi, MN
Al-Rikabi, AC
Elmazar, MMA
Citation: Oa. Badary et al., Inhibition of benzo(a)pyrene-induced forestomach carcinogenesis in mice bythymoquinone, EUR J CAN P, 8(5), 1999, pp. 435-440
Citation: Oa. Badary, Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice, J ETHNOPHAR, 67(2), 1999, pp. 135-142